Mesothelioma dose response following intraperitoneal injection of mineral fibres

The relationship between injected dose and the development of peritoneal mesotheliomas has been examined in rats using the UTCC standard reference samples of chrysotile, crocidolite and amosite as well as a sample of fibrous erionite from Oregon. Doses injected into the peritoneal cavity ranged from 0.005 to 25 mg and with each dust a clear dose response was found. The proportion of animals developing tumours increased with the amount of dust injected while the tumour induction period was reduced. When times to death from mesothelioma were analysed using standard hazard models, erionite was the most carcinogenic dust by mass followed by chrysotile, amosite and crocidolite. The hazard slopes for erionite, chrysotile and crocidolite, over the range of doses examined, were parallel while the slope for amosite was shallower. The relative hazards for the various dust types were also examined with dose expressed as the number of injected fibres in a range of sizes as measured by SEM. No combination of fibre dimensions was found at which the hazard for the four dust types was equal although when dose was expressed as the number of long fibres injected (> 8 microns in length) the hazard slopes for chrysotile, crocidolite and amosite were relatively close. The hazard level of erionite remained well above the other dust types regardless of how the dose was expressed.

Publication Number: P/91/20

First Author: Davis JMG

Other Authors: Bolton rE , Miller BG , Niven K

Publisher: Blackwell Publishing,9600 Garsington Road, Oxford, OX4 2DQ, UK,Oxford

Download Publication

COPYRIGHT ISSUES

Anyone wishing to make any commercial use of the downloadable articles on this page should contact the publishers of the journals. Please see the copyright notices on the journals' home pages:

Permissions requests for Oxford Journals Online should be made to: [email protected]

Permissions requests for Occupational Health Review articles should be made to the editor at [email protected]